Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic and pharmacodynamic observational study of common chemotherapies in elderly patients with cancer
NL-OMON47924Active, not recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Aug 2012
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of docetaxel, paclitaxel, doxorubicin, gemcitabine, vinorelbine and 1 more in cancer (6 cohorts), sponsored by Netherlands Cancer Institute. Primary endpoint: Pharmacokinetic parameters. Started Aug 2012; status: active, not recruiting.
02
Drugs
docetaxelpaclitaxeldoxorubicingemcitabinevinorelbine
03
Conditions
cancer
Beyond the preview
Go deeper on NL-OMON47924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47924.